GO:0043085 positive regulation of catalytic activity: Enzyme Activation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043085 (positive regulation of catalytic activity) is defined as any process that activates or increases the activity of an enzyme [1, 2, 5].
• Enzyme activation can occur through post-translational modifications, allosteric binding, protein-protein interactions, or changes in cellular localization [4, 7, 8].
• Dysregulation of enzyme activation is linked to cancer, metabolic disorders, and immune dysfunction [1, 4, 5].
• Key regulatory proteins include p300/CBP, AMPK, HERC5, and V-ATPase-associated TLDc proteins [1, 4, 5, 8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting causal roles of enzymes and their regulators [1, 7].
• Studying this process requires integrating biochemical assays, proteomics, and functional genomics [3, 6].
Description
Positive regulation of catalytic activity (GO:0043085) encompasses any process that activates or increases the activity of an enzyme [1, 2, 5]. This biological process is fundamental to cellular signaling, metabolism, and homeostasis, as it ensures that enzymes are active only when and where needed [4, 7]. For researchers, understanding how enzyme activity is positively regulated provides insights into normal physiology and disease mechanisms, from cancer to metabolic syndromes [1, 5]. The term includes diverse mechanisms such as allosteric activation, post-translational modifications, and protein-protein interactions that enhance catalytic efficiency [4, 8]. Given the centrality of enzyme activation in drug discovery and synthetic biology, precise annotation and experimental modeling of GO:0043085 are critical [2, 6].
positive regulation of catalytic activity At A Glance
| GO ID | GO:0043085 |
|---|---|
| GO term | positive regulation of catalytic activity |
| Ontology | biological_process |
| Synonym | activation of enzyme activity, stimulation of enzyme activity, upregulation of enzyme activity |
| Major function | Enhances enzyme catalytic efficiency through diverse molecular mechanisms |
| Related processes | Enzyme activation, signal transduction, metabolic regulation |
| Disease relevance | Cancer, metabolic disorders, immune dysregulation |
| Research methods | CRISPR screens, biochemical assays, proteomics |
What Is GO:0043085?
GO:0043085, positive regulation of catalytic activity, refers to any process that activates or increases the activity of an enzyme. This includes direct activation of enzyme molecules, as well as upstream signaling events that lead to enhanced catalytic function. It is a biological process term that captures the positive modulation of enzyme activity, distinct from enzyme expression or stability.
Why Is positive regulation of catalytic activity Important in Cell Biology?
Positive regulation of catalytic activity is essential for maintaining cellular homeostasis and responding to environmental cues. Dysregulation of this process can lead to a wide range of diseases, including cancer, where hyperactive enzymes drive proliferation, and metabolic disorders, where impaired activation contributes to pathogenesis [1, 5]. Understanding the mechanisms of enzyme activation enables the development of targeted therapies and precision medicine approaches [4, 8].
• Controls key signaling pathways such as AMPK-dependent energy sensing.
• Regulates immune responses through enzymes like HERC5 and cGAS.
• Influences cancer progression via p300/CBP acetyltransferase activity.
• Modulates lysosomal and vesicular function through V-ATPase regulation.
• Affects drug metabolism and detoxification by activating cytochrome P450 enzymes.
• Plays a role in neurodegeneration through altered kinase and phosphatase activities.
• Enables synthetic biology circuits that require conditional enzyme activation.
• Provides targets for allosteric drugs and covalent activators.
• Underpins metabolic engineering strategies in biotechnology.
• Facilitates high-throughput screening for enzyme modulators.
What Happens During positive regulation of catalytic activity?
Signal Perception and Transduction
In simple terms: The cell senses a signal and passes it on to activate an enzyme.
Positive regulation often begins with extracellular or intracellular signals that trigger signaling cascades. For example, AMPK is activated by increases in AMP/ATP ratio, leading to phosphorylation of downstream targets. Similarly, HERC5-catalyzed ISGylation potentiates cGAS-mediated innate immunity, demonstrating how signal transduction can directly enhance enzyme activity.
Post-translational Modifications
In simple terms: Chemical tags are added to enzymes to turn them on.
Phosphorylation, ubiquitination, and ISGylation are common modifications that increase catalytic activity. Otubain 1 positively regulates p53 stability and activity through deubiquitination. HERC5-mediated ISGylation of cGAS enhances its enzymatic activity in immune responses.
Allosteric and Conformational Changes
In simple terms: The enzyme changes shape to become more active.
Binding of small molecules or proteins at allosteric sites can induce conformational shifts that increase catalytic efficiency. For instance, supramolecular regulation of catalytic activity for an amphiphilic pyrene-ruthenium complex demonstrates how non-covalent interactions can modulate enzyme-like activity.
Protein-Protein Interactions and Complex Assembly
In simple terms: Enzymes team up with other proteins to work better.
Interaction with regulatory subunits or scaffold proteins can enhance enzyme activity. Human V-ATPase function is positively and negatively regulated by TLDc proteins, illustrating how binding partners control catalytic output. Similarly, p300/CBP acetyltransferase activity is modulated by complex formation with transcription factors.
Localization and Substrate Availability
In simple terms: Moving an enzyme to the right place increases its activity.
Changes in subcellular localization can bring enzymes into proximity with substrates, effectively increasing catalytic activity. For example, bile salt hydrolase catalyses formation of amine-conjugated bile acids, a process dependent on localization and substrate access.
Key Genes Involved in GO:0043085 positive regulation of catalytic activity
The following genes and proteins are key players in positive regulation of catalytic activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EP300 | Histone acetyltransferase p300; activates transcription | Target in lineage-specific tumours |
| CREBBP | CBP acetyltransferase; coactivator | Cancer and developmental disorders |
| PRKAA1 | AMPK catalytic subunit; energy sensor | Metformin response, metabolic diseases |
| PRKAA2 | AMPK catalytic subunit | Metabolic regulation |
| HERC5 | E3 ligase; ISGylation of cGAS | Innate immunity |
| OTUB1 | Deubiquitinase; stabilizes p53 | Cancer and p53 regulation |
| ATP6V0A1 | V-ATPase subunit | Lysosomal function |
| TLDC1 | Regulates V-ATPase | V-ATPase positive regulation |
| TLDC2 | Regulates V-ATPase | V-ATPase positive regulation |
| BSH | Bile salt hydrolase | Gut microbiome metabolism |
| SOD1 | Superoxide dismutase | Oxidative stress |
| CASP3 | Caspase-3 | Apoptosis |
| MAPK1 | ERK2 kinase | Proliferation |
| AKT1 | Serine/threonine kinase | Survival signaling |
| MTOR | mTOR kinase | Growth and metabolism |
| GSK3B | Glycogen synthase kinase-3 beta | Wnt signaling |
| CDK2 | Cyclin-dependent kinase 2 | Cell cycle |
How Is positive regulation of catalytic activity Regulated?
Positive regulation of catalytic activity is itself tightly regulated. For example, AMPK activity is controlled by upstream kinases and phosphatases in response to energy status. HERC5-mediated ISGylation is regulated by interferon signaling. V-ATPase activity is modulated by TLDc proteins in a reversible manner. These regulatory layers ensure that enzyme activation is transient and context-specific.
positive regulation of catalytic activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EP300 | Cancer | Knockout in cancer cell lines |
| PRKAA1 | Type 2 diabetes | Point mutation in AMPK |
| HERC5 | Autoimmunity | Overexpression in immune cells |
| OTUB1 | Cancer | Knockout in p53-wildtype cells |
| ATP6V0A1 | Neurodegeneration | Knock-in of disease mutations |
Cancer
Hyperactivation of enzymes such as p300/CBP contributes to lineage-specific tumours, making them attractive therapeutic targets. Dysregulation of p53 deubiquitination by OTUB1 affects tumor suppression.
Metabolic Disorders
AMPK activation is central to metformin's therapeutic effects in diabetes and metabolic syndrome. Impaired enzyme activation can lead to insulin resistance and obesity.
Immune Dysfunction
HERC5-catalyzed ISGylation potentiates cGAS-mediated innate immunity, and its dysregulation may contribute to autoimmune diseases.
Neurodegeneration
Altered V-ATPase activity has been implicated in lysosomal storage disorders and neurodegeneration.
From positive regulation of catalytic activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X activate enzyme Y? | Knockout of gene X followed by enzyme activity assay |
| Does mutation A affect catalytic activity? | Point mutation knock-in |
| Can we tag the enzyme for live imaging? | Tagged knock-in |
| Is overexpression sufficient to activate pathway? | Overexpression cell line |
| Which regulators are essential? | CRISPR library screening |
| What is the transcriptomic impact? | RNA-seq after knockout |
How to Study the positive regulation of catalytic activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Catalytic rate | Drug screening |
| Western blot | Protein levels and modifications | Validation of activation |
| Co-immunoprecipitation | Protein interactions | Identifying regulators |
| RNA-seq | Transcriptional changes | Pathway analysis |
| CRISPR screen | Gene essentiality | Discovery of regulators |
| Mass spectrometry | Post-translational modifications | ISGylation detection |
| FRET biosensor | Real-time activity | Live-cell imaging |
Biochemical Enzyme Assays
Direct measurement of catalytic activity using fluorogenic or colorimetric substrates is the gold standard. For example, superoxide dismutase activity can be assessed using peptide-based nickel(II) complexes.
Proteomics and Post-translational Modification Analysis
Mass spectrometry-based proteomics can identify modifications such as ISGylation that regulate enzyme activity.
CRISPR Screens
Genome-wide knockout or activation screens can uncover genes that positively regulate catalytic activity.
Live-cell Imaging
Fluorescently tagged enzymes and substrates allow real-time monitoring of activation dynamics.
How CRISPR Can Be Used to Study GO:0043085 positive regulation of catalytic activity
Knockout
CRISPR knockout of candidate genes can determine whether they are required for positive regulation of catalytic activity. For example, knocking out EP300 reduces acetyltransferase activity in cancer cells.
Point Mutation
Introducing specific point mutations can mimic or abolish activation sites. For instance, mutating AMPK phosphorylation sites can test their role in metformin response.
Knock-in
Knock-in of tagged or mutant alleles allows precise tracking of enzyme activation. Tagged knock-in of ATP6V0A1 enables live imaging of V-ATPase regulation.
Overexpression
Overexpression of a gene can test sufficiency for enzyme activation. Overexpressing HERC5 enhances cGAS-mediated immunity.
How EDITGENE Supports positive regulation of catalytic activity Research
Researchers studying positive regulation of catalytic activity-related genes often need to determine whether a candidate gene is causally involved in enzyme activation or is merely correlated. EDITGENE provides comprehensive CRISPR services to address these questions with precision.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of catalytic activity research.
Frequently Asked Questions About positive regulation of catalytic activity
What is GO:0043085?
GO:0043085 is the Gene Ontology term for positive regulation of catalytic activity, defined as any process that activates or increases the activity of an enzyme [1, 2, 5].
What genes are involved in positive regulation of catalytic activity?
Key genes include EP300, CREBBP, PRKAA1, HERC5, OTUB1, and ATP6V0A1, among others [1, 4, 5, 7, 8].
How is enzyme activity positively regulated?
Through mechanisms such as post-translational modifications, allosteric binding, protein-protein interactions, and changes in localization [4, 7, 8].
What diseases are linked to dysregulated enzyme activation?
Cancer, metabolic disorders, immune dysfunction, and neurodegeneration [1, 4, 5, 8].
What experimental models are used to study GO:0043085?
CRISPR knockout, point mutation, knock-in, overexpression, and library screening [1, 5, 8].
What is the role of AMPK in positive regulation of catalytic activity?
AMPK is activated by energy stress and phosphorylates downstream enzymes to increase their activity.
How does HERC5 regulate enzyme activity?
HERC5 catalyzes ISGylation of cGAS, enhancing its enzymatic activity in innate immunity.
What is the clinical relevance of p300/CBP activation?
p300/CBP acetyltransferase activity is implicated in lineage-specific tumours and is a drug target.
Can CRISPR be used to study enzyme activation?
Yes, CRISPR knockout, point mutation, and knock-in models are widely used to dissect regulatory mechanisms [1, 7].
What methods measure positive regulation of catalytic activity?
Enzyme activity assays, proteomics, CRISPR screens, and live-cell imaging [3, 6, 8].
Conclusion
Positive regulation of catalytic activity (GO:0043085) is a fundamental biological process that controls enzyme function in health and disease. Understanding its mechanisms through CRISPR-based models and biochemical assays is essential for developing targeted therapies. EDITGENE offers a full suite of services to accelerate this research.
References
- 1. Lasko LM et al.. 2017. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.. Nature 550(7674):128-132 PMID: 28953875
- 2. Dai N et al.. 2021. Supramolecular Regulation of Catalytic Activity for an Amphiphilic Pyrene-Ruthenium Complex in Water.. Chemistry 27(45):11567-11573 PMID: 34060163
- 3. Rimal B et al.. 2024. Bile salt hydrolase catalyses formation of amine-conjugated bile acids.. Nature 626(8000):859-863 PMID: 38326609
- 4. Chu L et al.. 2024. HERC5-catalyzed ISGylation potentiates cGAS-mediated innate immunity.. Cell Rep 43(3):113870 PMID: 38421872
- 5. Hasanvand A. 2022. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.. Inflammopharmacology 30(3):775-788 PMID: 35419709
- 6. Guinard P et al.. 2024. Outstanding Superoxide Dismutase Catalytic Activity Of Simple Peptide-Based Nickel(II) Complexes.. Angew Chem Int Ed Engl 63(41):e202409343 PMID: 39012328
- 7. Sun XX et al.. 2012. Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.. EMBO J 31(3):576-92 PMID: 22124327
- 8. Oot RA et al.. 2024. Human V-ATPase function is positively and negatively regulated by TLDc proteins.. Structure 32(7):989-1000.e6 PMID: 38593795
